Sambrook, Philip N.

Obesity Is Not Protective against Fracture in Postmenopausal Women: GLOW

Compston, J. E., Watts, N. B., Chapurlat, R., Cooper, C., Boonen, S., Greenspan, S., Pfeilschifter, J., Silverman, S., Díez-Pérez, A., Lindsay, R., et al. (2011) · The American Journal of Medicine

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 552

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

Reid, D. M., Devogelaer, J.-P., Saag, K., Roux, C., Lau, C.-S., Reginster, J.-Y., Papanastasiou, P., Ferreira, A., Hartl, F., Fashola, T., et al. (2009) · The Lancet

Bone health and osteoporosis researchBone health and treatments

Cited by 527

Hormonal and Biochemical Parameters in the Determination of Osteoporosis in Elderly Men*

Center, J. R., Nguyen, T. V., Sambrook, P. N., & Eisman, J. A. (1999) · The Journal of Clinical Endocrinology & Metabolism

Bone health and osteoporosis researchHormonal and reproductive studies

Cited by 189

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

McClung, M. R., O'Donoghue, M. L., Papapoulos, S. E., Bone, H., Langdahl, B., Saag, K. G., Reid, I. R., Kiel, D. P., Cavallari, I., Bonaca, M. P., et al. (2019) · The Lancet Diabetes & Endocrinology

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 169

Serum Parathyroid Hormone Predicts Time to Fall Independent of Vitamin D Status in a Frail Elderly Population

Sambrook, P. N., Chen, J. S., March, L. M., Cameron, I. D., Cumming, R. G., Lord, S. R., Zochling, J., Sitoh, Y. Y., Lau, T. C., Schwarz, J., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism

Balance, Gait, and Falls PreventionVitamin D Research Studies

Cited by 118

Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids

Devogelaer, J.-P., Sambrook, P., Reid, D. M., Goemaere, S., Ish-Shalom, S., Collette, J., Su, G., Bucci-Rechtweg, C., Papanastasiou, P., & Reginster, J.-Y. (2013) · Rheumatology

Bone health and osteoporosis researchBone health and treatments

Cited by 19

Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate

Sambrook, P. N., Roux, C., Devogelaer, J.-P., Saag, K., Lau, C.-S., Reginster, J.-Y., Bucci-Rechtweg, C., Su, G., & Reid, D. M. (2012) · Bone

Bone health and osteoporosis researchBone health and treatments

Cited by 3